Compound information
- Natural Products
- ZC892777
- Molecular Formula
- C14H16FN5OS
- Molecular Weight
- 321.105959352 g/mol
- Structure
-
- IUPAC Name
- N-(3-fluorophenyl)-4-(3-methyl-1,2,4-thiadiazol-5-yl)piperazine-1-carboxamide
- InChI
- InChI=1S/C14H16FN5OS/c1-10-16-14(22-18-10)20-7-5-19(6-8-20)13(21)17-12-4-2-3-11(15)9-12/h2-4,9H,5-8H2,1H3,(H,17,21)
- InChI Key
- LFNWBGHQGCXZJH-UHFFFAOYSA-N
- SMILES
- Cc1nsc(N2CCN(C(=O)Nc3cccc(F)c3)CC2)n1
- Source
- ZINC000072311229
Warheads
- Urea carbonyl
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 22 | Ring Count | 3 |
Heteroatom Count | 8 | Rotatable Bond Count | 2 |
Hydrogen Bond Acceptor Count | 5 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 61.36 Å2 | LogP | 2.624 |
LogS | -3.646 | LogD | 2.778 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.343 | Pgp substrate | 0.2 |
HIA | 0.967 | F20 % | 0.993 |
F30 % | 0.984 | Caco-2 | -4.632 |
MDCK | -4.814 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.33 | PPB | 98.866 |
VD | 0.999 | Fu | 1.546 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.895 | CYP1A2 substrate | 0.788 |
CYP2A6 substrate | 0.679 | CYP2B6 substrate | 0.71 |
CYP2C19 inhibitor | 0.876 | CYP2C19 substrate | 0.878 |
CYP2C8 substrate | 0.777 | CYP2C9 inhibitor | 0.39 |
CYP2C9 substrate | 0.907 | CYP2D6 inhibitor | 0.246 |
CYP2D6 substrate | 0.953 | CYP2E1 substrate | 0.5 |
CYP3A4 inhibitor | 0.067 | CYP3A4 substrate | 0.998 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.471 | CL | 3.908 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.654 | Hepatotoxicity | 0.843 |
Mutagenicity | 0.007 | Rat Oral Acute Toxicity | 0.286 |
FDAMDD | 0.643 | Skin Sensitization | 0.514 |
Carcinogenicity | 0.976 | Eye Corrosion | 0.001 |
Eye Irritation | 0.001 | Respiratory Toxicity | 0.966 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.422 | IGC50 | 2.277 |
LC50FM | -4.039 | LC50DM | -5.283 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.213 | NR-AR-LBD | 0.219 |
NR-AhR | 0.735 | NR-Aromatase | 0.026 |
NR-ER | 0.507 | NR-ER-LBD | 0.266 |
NR-PPAR-gamma | 0.377 | SR-ARE | 0.823 |
SR-ATAD5 | 0.679 | SR-HSE | 0.063 |
SR-MMP | 0.012 | SR-p53 | 0.035 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.